Read the latest Presentations from Asarina Pharma, containing full details of Sepranolone, our first-in-class therapy for PMDD, our science, pipeline and business intelligence.
Asarina Pharma TLR Presentation April 22, 2020 (pdf)
Asarina Pharma digital R&D Day presentation March 26, 2020 (pdf)
Asarina Pharma presentation at JPM in San Francisco January 2020 (pdf)
Asarina Pharma presentation at DnB in Oslo December 2019 (pdf)
Meet our CEO Peter Nordkild, COO Karin Ekberg and CBO Otto Skolling as they present to investors in Stockholm, Gothenburg and online.